REFERENCES
1. Schache AG, Powell NG, Cuschieri KS, et al. HPV-related oropharynx
cancer in the United Kingdom: an evolution in the understanding of
disease etiology. Cancer Res. 2016;76(22):6598-6606.
https://doi.org/10.1158/0008-5472.CAN-16-0633
2. Shaha AR. Mandibulotomy and mandibulectomy in difficult tumors of the
base of the tongue and oropharynx. Semin Surg Oncol.1991;7(1):25-30. doi: 10.1002/ssu.2980070107.
3. O’Hara J, MacKenzie K. Surgical versus non-surgical management of
early stage oropharyngeal squamous cell carcinoma. Eur Arch
Otorhinolaryngol. 2011;268(3):437-442.
https://doi.org/10.1007/s00405-010-1362-4
4. Pignon J-P, Le Maitre A, Maillard E, Bourhis J, Group M-NC.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an
update on 93 randomised trials and 17,346 patients. Radiother
Oncol . 2009;92(1):4-14. https://doi.org/10.1016/j.radonc.2009.04.014
5. Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head
and neck cancer: a 5 year prospective study. Laryngoscope.2005;115(12):2183-2192.
https://doi.org/10.1097/01.MLG.0000181507.69620.14
6. Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head
and neck cancer patients following intensity modulated radiotherapy
(IMRT). Radiat Oncol . 2011;6(1):1.
https://doi.org/10.1186/1748-717X-6-1
7. Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head
and neck cancer treatment: patients’ perspectives. Otolaryngol
Head Neck Surg. 2011;145(5):767-771.
https://doi.org/10.1177/0194599811414506
8. Paleri V, Patterson J. Use of gastrostomy in head and neck cancer: a
systematic review to identify areas for future research. Clin
Otolaryngol. 2010;35(3):177-189.
https://doi.org/10.1111/j.1749-4486.2010.02128.x
9. Weinstein GS, O’Malley BW, Cohen MA, Quon H. Transoral robotic
surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol
Head Neck Surg. 2010;136(11):1079-1085.
https://doi.org/10.1001/archoto.2010.191
10. Iseli TA, Kulbersh BD, Iseli CE, Carroll WR, Rosenthal EL, Magnuson
JS. Functional outcomes after transoral robotic surgery for head and
neck cancer. Otolaryngol Head Neck Surg. 2009;141(2):166-171.
https://doi.org/10.1016/j.otohns.2009.05.014
11. Dziegielewski PT, Teknos TN, Durmus K, et al. Transoral Robotic
Surgery for Oropharyngeal Cancer: Long-term Quality of Life and
Functional Outcomes. JAMA Otolaryngol Head Neck Surg.2013;139(11):1099-1108. https://doi.org/10.1001/jamaoto.2013.2747
12. Ling DC, Chapman BV, Kim J, et al. Oncologic outcomes and
patient-reported quality of life in patients with oropharyngeal squamous
cell carcinoma treated with definitive transoral robotic surgery versus
definitive chemoradiation. Oral Oncol. 2016;61:41-46.
https://doi.org/10.1016/j.oraloncology.2016.08.004
13. Achim V, Bolognone RK, Palmer AD, et al. Long-term functional and
quality-of-life outcomes after transoral robotic surgery in patients
with oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg.2018;144(1):18-27. https://doi.org/10.1001/jamaoto.2017.1790
14. Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional
outcomes after TORS for oropharyngeal cancer: a systematic review.Eur Arch Otorhinolaryngol . 2015;272(2):463-471.
https://doi.org/10.1007/s00405-014-2985-7
15. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for
oropharyngeal squamous cell carcinoma: a prospective study of
feasibility and functional outcomes. Laryngoscope009;119(11):2156-2164. https://doi.org/10.1002/lary.20647
16. Moore EJ, Olsen SM, Laborde RR, et al. Long-term Functional and
Oncologic Results of Transoral Robotic Surgery for Oropharyngeal
Squamous Cell Carcinoma. Mayo Clin Proc. 2012;87(3):219-225.
https://doi.org/10.1016/j.mayocp.2011.10.007
17. Sharma A, Patel S, Baik FM, et al. Survival and Gastrostomy
Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral
Robotic Surgery vs Chemoradiotherapy. JAMA Otolaryngol Head Neck
Surg. 2016;142(7):691-697. https://doi.org/10.1001/jamaoto.2016.1106
18. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA,
Magnuson JS. Patient-Perceived and Objective Functional Outcomes
Following Transoral Robotic Surgery for Early Oropharyngeal Carcinoma.Arch Otolaryngol Head Neck Surg. 2011;137(11):1112-1116.
https://doi.org/10.1001/archoto.2011.172
19. Shin MJ KJ, Lee SB, Lee SY. Speech mechanism screening test. Seoul,
South Korea: Hakjisa Publisher; 2010.
20. Bressmann T, Sader R, Whitehill TL, Samman N. Consonant
intelligibility and tongue motility in patients with partial
glossectomy. J Oral Maxillofac Surg. 2004;62(3):298-303.
https://doi.org/10.1016/j.joms.2003.04.017
21. Fynes MM, Smith C, Brodsky MB. The Modified Barium Swallow Study:
When, How, and Why? Appl Radiol. 2019;48:3-8.
22. Brierley JD, Gospodarowicz MK, Wittekind C (Eds.) TNM classification
of malignant tumours. Oxford, UK; Wiley-Blackwell; 2017.
23. De Almeida JR, Byrd JK, Wu R, et al. A systematic review of
transoral robotic surgery and radiotherapy for early oropharynx cancer:
a systematic review. Laryngoscope. 2014;124(9):2096-2102.
https://doi.org/10.1002/lary.24712
24. Su HK, Ozbek U, Likhterov I, et al. Safety of transoral surgery for
oropharyngeal malignancies: an analysis of the ACS NSQIP.Laryngoscope. 2016;126(11):2484-2491.
https://doi.org/10.1002/lary.26024